EDGAR Filing Documents for 0001193125-16-647461

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001193125-16-647461

Filing Date

2016-07-14

Accepted

2016-07-13 18:22:03

Documents

Group Members

QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FUND V LP

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13D	d206238dsc13d.htm	SC 13D	84263
2	EX-1	d206238dex991.htm	EX-99.1	13127
	Complete submission text file	0001193125-16-647461.txt		99163

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036

Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800

QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85963 | Film No.: 161766308
SIC: 2834 Pharmaceutical Preparations